Clinical Trial Update: This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-finding and 2-year extension study evaluating the safety and tolerability of tinlarebant in adolescents with Stargardt disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stargardt Disease

Drugs mentioned

• Tinlarebant

Snippet

Sponsor: RBP4 Pty Ltd | Conditions: Stargardt Disease | Phase 1, Phase 2 | Status: COMPLETED